USD 19.48
(-5.21%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 360.15 Million USD | 8.6% |
2022 | 330.2 Million USD | -5.84% |
2021 | 389.62 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 93.69 Million USD | 38.93% |
2024 Q2 | 101.81 Million USD | 4.96% |
2024 Q3 | -189.68 Million USD | 3.16% |
2023 Q1 | 93.57 Million USD | 0.0% |
2023 Q2 | 100.4 Million USD | 7.31% |
2023 FY | - USD | 8.6% |
2022 FY | - USD | -5.84% |
2021 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Ardent Health Partners, LLC | 356.68 Million USD | -0.973% |